Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2011
|
| gptkbp:ATCCode |
C09CA09
|
| gptkbp:contraindication |
pregnancy
severe hepatic impairment |
| gptkbp:drugClass |
angiotensin II receptor blocker
|
| gptkbp:excretion |
urine
feces |
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
azilsartan medoxomil
|
| gptkbp:halfLife |
11 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Edarbi
|
| gptkbp:indication |
treatment of high blood pressure
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Daiichi_Sankyo
|
| gptkbp:mechanismOfAction |
blocks angiotensin II type 1 receptors
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
dizziness fatigue |
| gptkbp:usedFor |
hypertension
|
| gptkbp:bfsParent |
gptkb:Takeda
gptkb:Takeda_(Japan) |
| gptkbp:bfsLayer |
6
|